Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.18 | 0.003 |
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.19 | 0.003 |
mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |